While the new Shield blood test may motivate more people to get screened for colorectal cancer, it also comes with downsides, ...

A rival CEO's confrontational social media post underscored the high stakes in the race to develop and deploy cancer ...

Positive results of a colon cancer study conducted by Exact Sciences prompt the CEO of competitor Guardant Health to publicly ...

The initial results suggest that Exact’s test could be an alternative to others on the market, but the findings come from a ...

Exact’s test could compete with Guardant Health’s Shield blood test, which received approval from the Food and Drug Administration in July.

The American Urological Association recommends that you get a baseline PSA test between ages 45 and 50, but screening can ...

Elevated IL-6 levels were linked to an increased risk for obesity-related cancers in patients with newly diagnosed type 2 ...

Drug treatments for blood cancers have evolved. In the past, myeloma patients received two drugs in sequence—two after two.

An experimental blood test could one day help identify people most likely to develop severe lung problems like chronic ...

Urologist Dr. Arpeet Shah discuses the importance of early screenings for Black men and the benefits of HIFU therapy.

Blood tests for cancer detection, known as liquid biopsies, can still be unreliable, but progress is being made. Competition between different diagnostics companies is also intensifying.

Exact Sciences released data from a study of its blood-based colorectal cancer screening test that showed sensitivities of 88.3% for colorectal cancer and 31.2% for advanced precancerous lesions.